ANGPharmaceuticals
AngloGold Ashanti plc — Profit & Loss Statement
₹18.42
-5.71%
AngloGold Ashanti plc Profit & Loss Statement (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Revenue | 92.85 Cr | 146.11 Cr | 219.78 Cr | 354.12 Cr | — |
| Operating Revenue | 92.85 Cr | 146.11 Cr | 219.78 Cr | 354.12 Cr | — |
| Tax Effect Of Unusual Items | 0.00 | -0.09 Cr | -0.04 Cr | -0.35 Cr | — |
| Tax Rate For Calcs | 0.21 | 0.05 | 0.30 | 0.25 | — |
| Normalized EBITDA | -0.26 Cr | 10.35 Cr | 23.30 Cr | 69.09 Cr | — |
| Total Unusual Items | 0.00 | -1.74 Cr | -0.13 Cr | -1.43 Cr | — |
| Total Unusual Items Excluding Goodwill | 0.00 | -1.74 Cr | -0.13 Cr | -1.43 Cr | — |
| Net Income From Continuing Operation Net Minority Interest | -12.41 Cr | -10.14 Cr | -0.26 Cr | 40.32 Cr | — |
| Reconciled Depreciation | 6.27 Cr | 8.37 Cr | 9.35 Cr | 5.88 Cr | — |
| Reconciled Cost Of Revenue | 59.62 Cr | 95.11 Cr | 150.59 Cr | 227.98 Cr | — |
| EBITDA | -0.26 Cr | 8.62 Cr | 23.17 Cr | 67.66 Cr | — |
| EBIT | -7.02 Cr | 0.24 Cr | 13.82 Cr | 61.78 Cr | — |
| Net Interest Income | -8.69 Cr | -10.96 Cr | -11.84 Cr | -9.13 Cr | — |
| Interest Expense | 8.69 Cr | 10.96 Cr | 11.19 Cr | 8.28 Cr | — |
| Normalized Income | -12.41 Cr | -8.50 Cr | -0.17 Cr | 41.40 Cr | — |
| Net Income From Continuing And Discontinued Operation | -12.41 Cr | -10.14 Cr | -0.26 Cr | 40.32 Cr | — |
| Total Expenses | 101.87 Cr | 144.83 Cr | 212.97 Cr | 290.50 Cr | — |
| Diluted NI Availto Com Stockholders | -12.41 Cr | -10.14 Cr | -0.26 Cr | 40.32 Cr | — |
| Net Income Common Stockholders | -12.41 Cr | -10.14 Cr | -0.26 Cr | 40.32 Cr | — |
| Otherunder Preferred Stock Dividend | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Net Income | -12.41 Cr | -10.14 Cr | -0.26 Cr | 40.32 Cr | — |
| Net Income Including Noncontrolling Interests | -12.41 Cr | -10.14 Cr | -0.26 Cr | 40.32 Cr | — |
| Net Income Continuous Operations | -12.41 Cr | -10.14 Cr | -0.26 Cr | 40.32 Cr | — |
| Tax Provision | -3.29 Cr | -0.57 Cr | 2.89 Cr | 13.18 Cr | — |
| Pretax Income | -15.70 Cr | -10.71 Cr | 2.63 Cr | 53.50 Cr | — |
| Other Non Operating Income Expenses | 2.01 Cr | 0.70 Cr | 8.23 Cr | 0.61 Cr | — |
| Special Income Charges | 0.00 | -1.74 Cr | -0.13 Cr | -1.43 Cr | — |
| Net Non Operating Interest Income Expense | -8.69 Cr | -10.96 Cr | -11.84 Cr | -9.13 Cr | — |
| Interest Expense Non Operating | 8.69 Cr | 10.96 Cr | 11.19 Cr | 8.28 Cr | — |
| Operating Income | -9.03 Cr | 1.28 Cr | 6.81 Cr | 63.62 Cr | — |
| Operating Expense | 42.25 Cr | 49.72 Cr | 62.38 Cr | 62.52 Cr | — |
| Other Operating Expenses | 18.04 Cr | 21.99 Cr | 17.23 Cr | 17.00 Cr | — |
| Depreciation And Amortization In Income Statement | 6.76 Cr | 8.37 Cr | 9.35 Cr | 5.88 Cr | — |
| Depreciation Income Statement | 6.76 Cr | 8.37 Cr | 9.35 Cr | 5.88 Cr | — |
| Gross Profit | 33.22 Cr | 51.00 Cr | 69.19 Cr | 126.14 Cr | — |
| Cost Of Revenue | 59.62 Cr | 95.11 Cr | 150.59 Cr | 227.98 Cr | — |
| Interest Income | — | 0.53 Cr | 0.64 Cr | 0.29 Cr | 0.20 Cr |
| Rent Expense Supplemental | — | 0.32 Cr | 0.36 Cr | 0.19 Cr | 0.25 Cr |
| Diluted Average Shares | — | 1.31 Cr | 1.31 Cr | 1.04 Cr | 1.30 Cr |
| Basic Average Shares | — | 1.31 Cr | 1.31 Cr | 1.04 Cr | 1.30 Cr |
| Diluted EPS | — | -7.77 | -0.20 | 38.89 | 5.42 |
| Basic EPS | — | -7.77 | -0.20 | 38.89 | 5.42 |
| Other Special Charges | — | 1.56 Cr | -0.84 Cr | 0.11 Cr | — |
| Write Off | — | 0.90 Cr | 0.98 Cr | 1.33 Cr | 1.12 Cr |
| Total Other Finance Cost | — | 1.09 Cr | 1.29 Cr | 1.14 Cr | 0.37 Cr |
| Interest Income Non Operating | — | 0.53 Cr | 0.64 Cr | 0.29 Cr | 0.20 Cr |
| Selling General And Administration | — | 4.35 Cr | 8.00 Cr | 12.34 Cr | 5.30 Cr |
| Selling And Marketing Expense | — | 3.57 Cr | 7.28 Cr | 9.94 Cr | 4.76 Cr |
| General And Administrative Expense | — | 0.78 Cr | 0.71 Cr | 2.40 Cr | 0.54 Cr |
| Rent And Landing Fees | — | 0.32 Cr | 0.36 Cr | 0.19 Cr | 0.25 Cr |
| Research And Development | — | — | 0.00 | 0.25 Cr | — |
| Net Income Discontinuous Operations | — | — | — | — | 0.00 |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on AngloGold Ashanti plc
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.